Clinical Trials Browser

Phase 2/3 × Methotrexate × Gynecologic × Clear all

NCT03885388 2019-03-21

Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma （GTN） Patients With Score of 5-6

Phase 2/3 Unknown

Gestational Trophoblastic Disease, Drug-Related Side Effects and Adverse Reactions

NCT02606539 2017-03-22

SVCGTN

Phase 2/3 Unknown

Gestational Trophoblastic Disease